Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma

NCT04976478 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Cervical Squamous Cell Carcinoma

Interventions

DRUG: Nimotuzumab
RADIATION: EBRT combined with brachytherapy

Sponsor

Peking University Third Hospital